Hello, Guest
Login
Sign Up
 
 

Protect Yourself Against Penny Stock Scams ( RAD, PPG, ARIA, WSM )

HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.

 
 
Repost This

Los Angelas, CA -- (SBWIRE) -- 09/11/2012 -- Shares of Rite Aid Corporat (NYSE:RAD) are trading at $1.27 and is +6.04% from its 50-day Moving Average price of $1.1977 and -9.98% from its 200-day Moving Average price of $1.4108. The average trading volume is 6084640 shares and its market capitalization is $1.127B. It looks like Rite Aid Corporation (NYSE:RAD) is starting to turn back up and indicators are giving the first bullish signs. I’m looking to see this stock re-test its July highs shortly. The MACD is increasing & stock price has regained its position above the 50-day MA. The nearest trend is in favour of Bulls and RAD has room to go higher. If the stock can break through $1.29, we should see strong volume drive the stock higher. Also watch out for other resistance levels at $1.39 which is the 200-day moving average.

Get Free Daily Investing Tips and Picks : Click Here

PPG Industries, I (NYSE:PPG) is very active today and traded between $114.35 - 116.79 with total traded volume of 1559916 shares. At a current price of 115.79, PPG is +2.65 - +2.34% from the previous close of $113.14. Moreover, At Current Market Price, PPG is in distance of +5.40% from its 50-day Moving Average price of $109.858 and +12.90% from its 200-day Moving Average price of $102.558. Paints and coatings maker PPG Industries (PPG) soared to intraday highs on an upgrade by a Jefferies analyst, who cited improving finances and the company's focus on boosting shareholder value. PPG shares were up nearly 3% to 116.38. He also raised his price target to 135, from 117.

Get Free Daily Investing Tips and Picks : Click Here

ARIAD Pharmaceuti (NasdaqNM:ARIA) reported EPS of -0.975. For the Current Fiscal year, the company is expected to report EPS of -1.32. For the Next Quarter and Next Year, the company is expected to report EPS of -0.36 and -1.23 respectively. At Current Market Price, ARIA is in distance of +13.91% from its 50-day Moving Average price of $19.6297 and +30.65% from its 200-day Moving Average price of $17.1141.Ariad Pharmaceutical (NASDAQ: ARIA) was upgraded by equities researchers at Bank of America from a “neutral” rating to a “buy” rating in a report issued on Monday. The firm currently has a $26.00 target price on the stock, up from their previous target price of $20.00. The analysts wrote, “Despite ARIA shares +80% YTD performance, we are upgrading from Neutral to Buy based on the favorable risk/reward profile on near term data for ‘113 in lung cancer and subsequent Phase 2 expansion results, as well as our less conservative view of valuation for lead drug PON. While our new PO of $26 (up from $20) does not reflect a large premium to the current stock price, we see 15-70% upside to shares following upcoming lung cancer data (Sept 28-30). The key near term risk to ARIA is negative results for ‘113 ($6/sh of our current valuation), which seems unlikely given trial progress and management’s enthusiasm.”

Get Analysts' Upgrades and Downgrades via Email : Click Here

Williams-Sonoma, (NYSE:WSM) is +1.03 - +2.42% from the previous close of $42.61. It traded between $42.67 - 43.8365 with total traded volume of 1694872 shares. Keep a close eye on WSM, as the stock has been showing unusual moves over the past weeks. At Current market price, WSM has recovered +52.96% from its 52-week Low of 28.53 and has Pulled back -0.46% from its 52-week high of 43.84. Citigroup boosted their EPS estimates on shares of Williams Sonoma (NYSE: WSM) in a research note issued on Monday. The firm currently has a “buy” rating and a $49.00 price target on the company’s shares. Several other analysts have also recently commented on the stock. For the quarter ended July 29 (Q2), Williams-Sonoma beat slightly on revenues and beat expectations on earnings per share. Compared to the prior-year quarter, revenue expanded and GAAP earnings per share grew significantly. Gross margins dropped, operating margins improved, net margins expanded.

Get Analysts' Upgrades and Downgrades via Email : Click Here

Disclaimer:
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com